跳至主要内容
临床试验/CTRI/2020/09/027968
CTRI/2020/09/027968尚未招募2/3 期

Comparative Prospective Phase II Clinical Study to Evaluate the Efficacy of Guduchyadi Kwatha in Urdhvaga Amlapitta.

Ayurved Mahavidya Nashik1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2020年9月25日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
chest burning reduced

研究概览

简要总结

According to Ayurveda any disease can be caused when there is vitiation of Agni, dosha, mala,dhatu, and manasbhava.if any factor among this is disturbed it is called as vikara .according to ayurved agni plays main role in the physiological functioning of the body. the main root cause of all disease in mandagni. ’viruddhaashana’ for example fish with milk , etc pittaprakopak Aahara like spicy Food ,tea and alcohol causes pitta dosha in our body gets exaggerate which lead to symptoms of urdhvag amlapitta.Guduchyadi kwatha is a combination of Guduchi, patola,Chitrak, and Nimba as given in yogratnakara. they have properties of deepana ,pachana, and pittashamana so we used this combination in urdhvag amlapitta.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
19.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • patients having symptoms of urdhvag amlapitta patients willing for trial and giving consent patient from all socio economic status.

排除标准

  • pregnent and lactating women patients having hepatic disorders and other complications patient suffering from any infectious diseases patient suffering from major illness.

结局指标

主要结局

chest burning reduced

时间窗: 21 days

vomiting reduced

时间窗: 21 days

abdominal pain reduced

时间窗: 21 days

次要结局

  • Hyperacidity Reduced(21 days)

研究者

发起方
Ayurved Mahavidya Nashik
申办方类型
Other [Govt Aided Institute]

研究点 (1)

Loading locations...

相似试验